Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation
- PMID: 36792011
- DOI: 10.1016/j.jtha.2023.02.006
Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation
Abstract
Background: Severe fever with thrombocytopenia syndrome (SFTS) virus (SFTSV) infection causes an emerging hemorrhagic fever in East Asia with a high mortality rate. Thrombocytopenia is a consistent feature of SFTS illness, but the mechanism remains elusive.
Objectives: We aimed to better understand the role of platelets in the pathophysiology of SFTSV infection, including the development of thrombocytopenia.
Methods: Using platelets from healthy volunteers and patients with SFTS, we evaluated the functional changes in platelets against SFTSV infection. We investigated the direct effect of glycoprotein VI on platelet-SFTSV interaction by quantitative real-time PCR, molecular docking, surface plasmon resonance spectrometry, flow cytometry, western blot, and platelet functional studies in vitro. Interactions of SFTSV and platelet-SFTSV complexes with macrophages were also determined by scanning electron microscope, quantitative real-time PCR, and flow cytometry.
Results: This study is the first to demonstrate that platelets are capable of harboring and producing SFTSV particles. Structural and functional studies found that SFTSVs bind platelet glycoprotein VI to potentiate platelet activation, including platelet aggregation, adenosine triphosphate release, spreading, clot retraction, coagulation, phosphatidylserine exposure, thrombus formation, and adherence. In vitro mechanistic studies highlighted that the interaction of platelets with human THP-1 cells promoted SFTSV clearance and suppressed cytokine production in macrophages. However, unwanted SFTSV replication in macrophages reciprocally aggravated SFTSV persistence in the circulation, which may contribute to thrombocytopenia and other complications during SFTSV infection.
Conclusion: These findings together highlighted the pathophysiological role of platelets in initial intrinsic defense against SFTSV infections, as well as intertwined processes with host immunity, which can also lead to thrombocytopenia and poor prognosis.
Keywords: GPVI; SFTSV; platelet activation; replication; thrombocytopenia.
Copyright © 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interests There are no competing interests to disclose.
Similar articles
-
Thrombocytopenia in Severe Fever with Thrombocytopenia Syndrome Due to Platelets With Altered Function Undergoing Cell Death Pathways.J Infect Dis. 2025 Feb 4;231(1):e183-e194. doi: 10.1093/infdis/jiae355. J Infect Dis. 2025. PMID: 38996045 Free PMC article.
-
Severe fever with thrombocytopenia syndrome virus induces platelet activation and apoptosis via a reactive oxygen species-dependent pathway.Redox Biol. 2023 Sep;65:102837. doi: 10.1016/j.redox.2023.102837. Epub 2023 Aug 1. Redox Biol. 2023. Retraction in: Redox Biol. 2024 Jul;73:103233. doi: 10.1016/j.redox.2024.103233. PMID: 37544244 Free PMC article. Retracted.
-
Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome.Sci Transl Med. 2018 Sep 19;10(459):eaat4162. doi: 10.1126/scitranslmed.aat4162. Sci Transl Med. 2018. PMID: 30232226 Clinical Trial.
-
Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review).Int J Mol Med. 2022 Sep;50(3):118. doi: 10.3892/ijmm.2022.5174. Epub 2022 Jul 20. Int J Mol Med. 2022. PMID: 35856413 Free PMC article. Review.
-
Severe fever with thrombocytopenia syndrome and its pathogen SFTSV.Microbes Infect. 2015 Feb;17(2):149-54. doi: 10.1016/j.micinf.2014.12.002. Epub 2014 Dec 11. Microbes Infect. 2015. PMID: 25498868 Review.
Cited by
-
SARS-CoV-2 Omicron variant infection affects blood platelets, a comparative analysis with Delta variant.Front Immunol. 2023 Sep 27;14:1231576. doi: 10.3389/fimmu.2023.1231576. eCollection 2023. Front Immunol. 2023. PMID: 37828997 Free PMC article.
-
Vaccine Development for Severe Fever with Thrombocytopenia Syndrome Virus in Dogs.J Microbiol. 2024 Apr;62(4):327-335. doi: 10.1007/s12275-024-00119-y. Epub 2024 Apr 18. J Microbiol. 2024. PMID: 38635002
-
Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations.Mil Med Res. 2024 Dec 16;11(1):78. doi: 10.1186/s40779-024-00581-0. Mil Med Res. 2024. PMID: 39676169 Free PMC article. Review.
-
Impact of Glucocorticoid Therapy on 28-Day Mortality in Patients Having Severe Fever with Thrombocytopenia Syndrome in an Intensive Care Unit: A Retrospective Analysis.J Inflamm Res. 2024 Oct 24;17:7627-7637. doi: 10.2147/JIR.S478520. eCollection 2024. J Inflamm Res. 2024. PMID: 39479263 Free PMC article.
-
Blood Urea Nitrogen-to-Serum Albumin Ratio Predicts Fatal Outcomes in Severe Fever with Thrombocytopenia Syndrome Patients.Am J Trop Med Hyg. 2024 May 28;111(1):113-120. doi: 10.4269/ajtmh.23-0811. Print 2024 Jul 3. Am J Trop Med Hyg. 2024. PMID: 38806039 Free PMC article.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources